Literature DB >> 24976509

Reduced lung function, C-reactive protein, and increased risk of cardiovascular mortality.

Kyoung-Bok Min1, Jin-Young Min.   

Abstract

BACKGROUND: We explored whether reduced lung function is a predictor of mortality due to cardiovascular or coronary artery disease (CVD or CAD), and, if this hypothesis is correct, whether C-reactive protein (CRP), a systemic inflammatory marker, is responsible for this association in a general population-based cohort. METHODS AND 
RESULTS: We used the Third Nutrition and Health Examination Survey (NHANES III) database and the NHANES III Linked Mortality File. A total of 13,310 participants ≥20 years of age who completed a spirometric test at baseline examination were included. On comparison of the participants in the lowest forced vital capacity percent predicted (FVC% pred) quartile with those in the highest quartile, the hazard ratio (HR) was 2.1 (95% CI: 1.7-2.6) for cardiovascular mortality and 2.2 (95% CI: 1.6-3.2) for coronary mortality. A similar association was observed for forced expiratory volume in 1 s percent predicted (FEV1% pred). When the participants with the highest FVC% pred or FEV1% pred (Q4) and low CRP (≤0.22 mg/dl) were defined as the reference group, the adjusted HR for cardiovascular mortality was significantly increased in the individuals with the lowest spirometric volume (Q1), and the risk was prominent in individuals with high CRP (>0.22 mg/dl).
CONCLUSIONS: There is a significant association between lung function parameters and death from CVD and CAD in the general population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24976509     DOI: 10.1253/circj.cj-14-0308

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  13 in total

1.  Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals.

Authors:  Matthew R Gingo; Mehdi Nouraie; Cathy J Kessinger; Ruth M Greenblatt; Laurence Huang; Eric C Kleerup; Lawrence Kingsley; Deborah K McMahon; Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2018-02

2.  Inflammatory markers and mortality among US adults with obstructive lung function.

Authors:  Earl S Ford; Timothy J Cunningham; David M Mannino
Journal:  Respirology       Date:  2015-03-04       Impact factor: 6.424

3.  Spirometric impairments, cardiovascular outcomes, and noncardiovascular death in older persons.

Authors:  Carlos A Vaz Fragoso; Peter H Van Ness; Terrence E Murphy; Gail J McAvay
Journal:  Respir Med       Date:  2018-02-27       Impact factor: 3.415

4.  Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality.

Authors:  Carlos H Martinez; David M Mannino; Fabian A Jaimes; Jeffrey L Curtis; MeiLan K Han; Nadia N Hansel; Alejandro A Diaz
Journal:  Ann Am Thorac Soc       Date:  2015-12

5.  FEV1 as a Standalone Spirometric Predictor and the Attributable Fraction for Death in Older Persons.

Authors:  Carlos A Vaz Fragoso; Peter H Van Ness; Gail J McAvay
Journal:  Respir Care       Date:  2019-10-29       Impact factor: 2.258

6.  Association between glycemic state and pulmonary function and effect of walking as a protective factor in subjects with diabetes mellitus.

Authors:  Ji Min Kim; Min Kyeong Kim; Kyong Hye Joung; Ju Hee Lee; Hyun Jin Kim; Bon Jeong Ku
Journal:  Ann Transl Med       Date:  2019-10

7.  Lung function impairment is not associated with the severity of acute coronary syndrome but is associated with a shorter stay in the coronary care unit.

Authors:  Fernando Casas-Méndez; Alicia Sánchez-de-la-Torre; Joan Valls; Manuel Sánchez-de-la-Torre; Jorge Abad; Joaquin Duran-Cantolla; Valentin Cabriada; Juan Fernando Masa; Joaquin Teran; Gerard Castella; Fernando Worner; Ferran Barbé
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

8.  Association of lung function with cardiovascular risk: a cohort study.

Authors:  Bin Wang; Yun Zhou; Lili Xiao; Yanjun Guo; Jixuan Ma; Min Zhou; Tingming Shi; Aijun Tan; Jing Yuan; Weihong Chen
Journal:  Respir Res       Date:  2018-11-06

9.  Reduced Lung Function and Cerebral Small Vessel Disease in Japanese Men: the Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA).

Authors:  Ruriko Seto-Yukimura; Emiko Ogawa; Takashi Hisamatsu; Sayuki Torii; Akihiko Shiino; Kazuhiko Nozaki; Akira Fujiyoshi; Katsuyuki Miura; Yasutaka Nakano; Hirotsugu Ueshima
Journal:  J Atheroscler Thromb       Date:  2018-02-16       Impact factor: 4.928

10.  Relationship Between Forced Vital Capacity and Framingham Cardiovascular Risk Score Beyond the Presence of Metabolic Syndrome: The Fourth Korea National Health and Nutrition Examination Survey.

Authors:  Hyung Koo Kang; Hye Yun Park; Byeong-Ho Jeong; Won-Jung Koh; Seong Yong Lim
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.